Clinical Trial: PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06897228) titled 'PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors' on March 20.

Brief Summary: A single-center, single-arm, dose-escalation exploratory clinical trial on the safety and efficacy of PANK-003 cell injection(Peripheral blood-derived allogeneic natural killer cells )combined with standard adjuvant chemotherapy after surgery in patients with solid tumors

Study Start Date: Feb. 18, 2024

Study Type: INTERVENTIONAL

Condition: Solid Tumors, Adult

Intervention: DRUG: PANK-003 cell injection

PANK-003 cell injection

Recruitment Status: RECRUITING

Sponsor: Shenzhen Celconta...